Review article · 2022 · Open access

Biomarkers for Alzheimer’s Disease in the Current State: A Narrative Review

Serafettin Gunes, Yumi Aizawa, Takuma Sugashi, Masahiro Sugimoto, Pedro Pereira Rodrigues

International Journal of Molecular Sciences, 23(9), 4962 · Published 29 April 2022 · DOI 10.3390/ijms23094962

Open PDFView at the publisherCite this paper

In brief

“Biomarkers for Alzheimer’s Disease in the Current State: A Narrative Review” is a 2022 review article by Serafettin Gunes and 4 co-authors, published in International Journal of Molecular Sciences. OpenAlex counts 135 citations as of 19 November 2026. It is open access under a CC BY licence: the full text is free to read at International Journal of Molecular Sciences.

Citations
135
Most cited in
2025 (46)
Field-weighted impact
2.96
References
60
Authors
5

Abstract

Alzheimer's disease (AD) has become a problem, owing to its high prevalence in an aging society with no treatment available after onset. However, early diagnosis is essential for preventive intervention to delay disease onset due to its slow progression. The current AD diagnostic methods are typically invasive and expensive, limiting their potential for widespread use. Thus, the development of biomarkers in available biofluids, such as blood, urine, and saliva, which enables low or non-invasive, reasonable, and objective evaluation of AD status, is an urgent task. Here, we reviewed studies that examined biomarker candidates for the early detection of AD. Some of the candidates showed potential biomarkers, but further validation studies are needed. We also reviewed studies for non-invasive biomarkers of AD. Given the complexity of the AD continuum, multiple biomarkers with machine-learning-classification methods have been recently used to enhance diagnostic accuracy and characterize individual AD phenotypes. Artificial intelligence and new body fluid-based biomarkers, in combination with other risk factors, will provide a novel solution that may revolutionize the early diagnosis of AD.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Gunes, S., Aizawa, Y., Sugashi, T., Sugimoto, M., & Rodrigues, P. P. (2022). Biomarkers for Alzheimer’s Disease in the Current State: A Narrative Review. International Journal of Molecular Sciences, 23(9), 4962. https://doi.org/10.3390/ijms23094962

MLA 9

Gunes, Serafettin, et al. “Biomarkers for Alzheimer’s Disease in the Current State: A Narrative Review.” International Journal of Molecular Sciences, vol. 23, no. 9, 2022, p. 4962. https://doi.org/10.3390/ijms23094962.

Chicago

Gunes, Serafettin, Yumi Aizawa, Takuma Sugashi, Masahiro Sugimoto, and Pedro Pereira Rodrigues. 2022. “Biomarkers for Alzheimer’s Disease in the Current State: A Narrative Review.” International Journal of Molecular Sciences 23 (9): 4962. https://doi.org/10.3390/ijms23094962.

Harvard

Gunes, S. et al. (2022) ‘Biomarkers for Alzheimer’s Disease in the Current State: A Narrative Review’, International Journal of Molecular Sciences, 23(9), p. 4962. doi:10.3390/ijms23094962.

IEEE

S. Gunes, Y. Aizawa, T. Sugashi, M. Sugimoto, and P. P. Rodrigues, “Biomarkers for Alzheimer’s Disease in the Current State: A Narrative Review,” International Journal of Molecular Sciences, vol. 23, no. 9, p. 4962, 2022, doi: 10.3390/ijms23094962.

BibTeX

@article{gunes2022biomarkers,
  title     = {{Biomarkers for Alzheimer’s Disease in the Current State: A Narrative Review}},
  author    = {Gunes, Serafettin and Aizawa, Yumi and Sugashi, Takuma and Sugimoto, Masahiro and Rodrigues, Pedro Pereira},
  journal   = {International Journal of Molecular Sciences},
  year      = {2022},
  volume    = {23},
  number    = {9},
  pages     = {4962},
  doi       = {10.3390/ijms23094962},
  url       = {https://doi.org/10.3390/ijms23094962}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202211
20232222
20243535
20254646
20263131

Its field-weighted citation impact is 2.96: it has been cited 2.96 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research

  • Alzheimer's disease
  • biomarkers
  • early diagnosis
  • non-invasive biomarkers
  • biological fluids
  • saliva
  • urine
  • blood

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Gunes, S., Aizawa, Y., Sugashi, T., Sugimoto, M., & Rodrigues, P. P. (2022). Biomarkers for Alzheimer’s Disease in the Current State: A Narrative Review. International Journal of Molecular Sciences, 23(9), 4962. https://doi.org/10.3390/ijms23094962

How many times has this paper been cited?

135 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at International Journal of Molecular Sciences: sign in and open the PDF from this page.

Who wrote this paper?

Serafettin Gunes, Yumi Aizawa, Takuma Sugashi, Masahiro Sugimoto, Pedro Pereira Rodrigues.

What is the DOI of this paper?

10.3390/ijms23094962, permanently at https://doi.org/10.3390/ijms23094962. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.